Search
Menu
Sheetak -  Cooling at your Fingertip 11/24 LB

Laserscope to Seek Approval for Laser Cancer Treatment

Facebook X LinkedIn Email
SAN JOSE, Calif., May 12 -- Laserscope will co-submit a Pre-Market Approval application to the US Food and Drug Administration for its Photodynamic Therapy (PDT) Laser Systems, in conjunction with Scotia Pharmaceuticals Ltd., UK's New Drug Application for Foscan. The submissions, expected to take place in September 1999, will be for the PDT treatment of head and neck cancer. Foscan has been assigned ``fast-track'' status by the FDA for the palliation of head and neck cancer. If granted, approval could come as early as six months after submission.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: May 1999
    News & FeaturesLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.